Adrian I. Pelaez
Oviedo, AS, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Immobilization of mercury and arsenic and microbial response in contaminated soil treated with coal-derived iron-modified carbon foams.
Journal: Journal of hazardous materials
Published: November 07, 2025
Immobilization of metal(loid)s in the soil-plant system using composites of sucrose foams and iron nanoparticles.
Journal: Journal of environmental management
Published: July 07, 2025
Evolution of Lung Disease Studied by Computed Tomography in Adults with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor.
Journal: Journal of imaging
Published: March 13, 2025
Epidemiology of the COVID-19 pneumonia in a group of hospitals from Madrid-Spain during the full period of the State of Alarm HM cohort.
Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Published: February 14, 2025
The Role of Triple CFTR Modulator Therapy in Reducing Systemic Inflammation in Cystic Fibrosis.
Journal: Lung
Published: January 21, 2025
Burden and Economic Impact of Respiratory Viral Infections in Adults Aged 60 and Older: A Focus on RSV.
Journal: Diseases (Basel, Switzerland)
Published: December 17, 2024
Circulating tumor DNA using a plasma-only assay predicts survival in patients with oligometastatic colorectal cancer after definitive therapy.
Journal: Journal of gastrointestinal oncology
Published: October 28, 2024
Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain.
Journal: Geriatrics (Basel, Switzerland)
Published: October 09, 2024
Evaluating the Effectiveness of Nirsevimab in Reducing Pediatric RSV Hospitalizations in Spain.
Journal: Vaccines
Published: September 17, 2024
More or less "modest" versus significant excess mortality due to COVID-19 deaths in Europe.
Journal: The Lancet regional health. Europe
Published: July 29, 2024
Unveiling the psychosocial impact of Elexacaftor/Tezacaftor/Ivacaftor therapy in Cystic Fibrosis patients.
Journal: BMC pulmonary medicine
Published: July 17, 2024
Last Updated: 09/26/2026